logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrew Brenner

uthealth san antonio
H指数:46
被引数:8,851

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CLTR-06 RESPECT-LM: PHARMACOKINETIC AND PHARMACODYNAMIC ASSESSMENT OF RHENIUM OBISBEMEDA IN LEPTOMENINGEAL METASTASES WITH EMERGING DATA FROM REPEATED DOSING (RESPECT-LMM)

CLTR-06 RESPECT-LM：雷尼姆奥比塞米达在软脑膜转移中的药代动力学和药效学评估，并包含重复给药的初步数据（RESPECT-LMM）

Neuro-Oncology Advances
IF4.1
2026-08-070
OA
Andrew Brenner; Henriette Balinda; Priya Kumthekar; Michael Schulder; Eva Galvan; Ande Bao; Joel Michalek; Fatema Ataei; Penny Vroman; William Phillips; John Floyd; Jonathan Yang; Marc Hedrick; Michael Youssef
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide

PRMT5抑制使胶质母细胞瘤肿瘤模型对替莫唑胺更敏感

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Onishi, Shumpei; Jayamohan, Sridharan; Chowdhury, Ashis; Rivas, Sarah; Otani, Yoshihiro; Murphy, Sara A.; Rivera-Caraballo, Kimberly A.; Walbridge, Stuart; Shah, Ashish H.; Sisay, Bayu; Maric, Dragan; Elkahloun, Abdel; Johnson, Kory; Heiss, John; Lee, Tae Jin; Kumbar, Sangamesh G.; Brown, Desmond A.; Yoo, Ji Young; Brenner, Andrew; Kaur, Balveen; Sareddy, Gangadhara R.; Banasavadi-Siddegowda, Yeshavanth Kumar
PHASE 1/2 RESPECT-GBM TRIAL OF RHENIUM (186RE) OBISBEMEDA IN RECURRENT GLIOBLASTOMA: SAFETY AND EFFICACY FROM THE PHASE 1 AND UPDATE ON PHASE 2

I期/II期 RESPECT-GBM 临床试验中 (186RE) OBISBEMEDA 治疗复发性胶质母细胞瘤：I期的安全性和有效性及II期更新情况

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Brenner, Andrew; Youssef, Michael; Schulder, Michael; Giglio, Pierre; Michalek, Joel; Bao, Ande; Phillips, William; Moore, Melissa; Rosol, Michael; Hedrick, Marc; Kelly, William; Floyd, John; Patel, Toral
Trial in Progress (TiP): Interim analysis of a Phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with Vitamin K in combination with Standard of Care (SOC) RT and TMZ in Glioblastoma Multiforme (GBM) patients without prior therapy

进行中试验（TiP）：一项关于BPM31510（氧化辅酶Q10的脂质纳米分散体）联合维生素K，与标准护理（SOC）放疗（RT）和替莫唑胺（TMZ）联用治疗未经前期治疗的胶质母细胞瘤（GBM）患者的II期研究的期中分析

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Nagpal, Seema; Stockdale, Brian; Cohen, Adam; Patil, Chirag; Vaillant, Brian; Elmore, Kevin; Brenner, Andrew; Juthani, Rupa; Reardon, David; Kendle, Ryan; Spira, Alexander; Wykretowicz, Jedrzej; Zhukova-Harrill, Valentina; Nie, Bing; Narain, Niven; Modur, Vijay
PHASE 1 MULTICENTER STUDY OF MULTIPLE DOSES OF RHENIUM (186RE) OBISBEMEDA (REYOBIQ) FOR LEPTOMENINGEAL METASTASES: RATIONALE, DESIGN, AND PRELIMINARY COHORT 1 DATA

PHASE 1多中心研究：钼 (186Re) 奥比塞米达 (REYOBIQ) 多剂量治疗软脑膜转移的原理、设计与初步队列1数据

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Brenner, Andrew; Kumthekar, Priya; Schulder, Michael; Galvan, Eva; Bao, Ande; Michalek, Joel; Vroman, Penny; Phillips, William; Floyd, John; Yang, Jonathan T.; Rosol, Michael; Hedrick, Marc; Youssef, Michael
Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial

铼(186Re)奥比斯贝玛达(186RNL)在复发性胶质瘤中的对流增强递送：一项多中心、单臂、1期临床试验

NATURE COMMUNICATIONS
IF15.7
2025-03-071
OA
Brenner, Andrew J.; Patel, Toral; Bao, Ande; Phillips, William T.; Michalek, Joel E.; Youssef, Michael; Weinberg, Jeffrey S.; Matsuoka, Carlos Kamiya; Hedrick, Marc H.; Lafrance, Norman; Moore, Melissa; Floyd, John R.
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma

血脑屏障通透性肽-紫杉醇结合物ANG1005在复发性高级别胶质瘤患者中的II期试验

NEURO-ONCOLOGY ADVANCES
IF4.1
2024-12-140
OAAI
Dmello, Crismita; Brenner, Andrew; Piccioni, David; Wen, Patrick Y.; Drappatz, Jan; Mrugala, Maciej; Lewis, Lionel D.; Schiff, David; Fadul, Camilo E.; Chamberlain, Marc; Kesari, Santosh; Ahluwalia, Manmeet; Ghosh, Debora; Sonabend, Adam M.; Kumthekar, Priya
A MULTICENTER, RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)
NEURO-ONCOLOGY
IF13.4
2024-11-110
PRE
Ahluwalia, Manmeet; Ciesielski, Michael; Abad, Ajay; Reardon, David; Ozair, Ahmad; Khosla, Atulya; Aiken, Robert; Barbaro, Marissa; Sinicrope, Kaylyn; Peereboom, David; Odia, Yazmin; Brenner, Andrew; Venur, Vyshak; Belal, Ahmed; Qiu, Jingxin; Schilero, Cathy; Casucci, Danielle; Mechtler, Laszlo; Fenstermaker, Robert
RHENIUM (186RE) OBISBEMEDA (RHENIUM NANOLIPOSOME,186RNL) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM): SUMMARY OF THE PHASE 1 DOSE ESCALATION STUDY AND PHASE 2 ADMINISTERED DOSE SELECTION

用于治疗软脑膜转移 (LM) 的铼 (186RE) OBISBEMEDA (铼纳米脂质体，186RNL): 1期剂量递增研究和2期给药剂量选择的总结

NEURO-ONCOLOGY
IF13.4
2024-11-110
PRE
Brenner, Andrew; Youssef, Michael; Kumthekar, Priya; Bao, Ande; Michalek, Joel; Phillips, William; Patel, Toral; Floyd, John; Hedrick, Marc; Juverdianu, Leonardo; Blouw, Barbara; Lafrance, Norman; Moore, Melissa
GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB
NEURO-ONCOLOGY
IF13.4
2024-10-171
PRE
Lassman, A.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; De Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E. M., V; Khasraw, M.; Lim, M.; Mellinghoff, I; Mikkelsen, T.; Perry, J.; Powell, A.; Sulman, E.; Tanner, K.; Weller, M.; Yung, W. K. A.; Blondin, N.; Brenner, A.; Butt, O.; de la Fuente, M., I; Drappatz, J.; Iwamoto, F.; Kim, L.; Lee, E.; Mantica, M.; Nabors, B.; Newton, H.; Schiff, D.; Walbert, T.; Weathers, S.; Cloughesy, T.; Wen, P. Y.

研究方向

暂未获取到该数据
R
Rajeshwar R. Tekmal
H 指数:42论文数:316被引数:5,606
R
Ratna K. Vadlamudi
H 指数:0论文数:1被引数:0
G
Gangadhara R. Sareddy
H 指数:0论文数:1被引数:0
U
Uday P. Pratap
H 指数:19论文数:165被引数:1,183
S
Suryavathi Viswanadhapalli
H 指数:0论文数:1被引数:0
R
Ratna K. Vadlamudi
H 指数:70论文数:616被引数:1.4万
L
Linda A. deGraffenried
H 指数:28论文数:196被引数:2,913
G
Gangadhara R. Sareddy
H 指数:31论文数:255被引数:2,836
S
Suryavathi Viswanadhapalli
H 指数:24论文数:283被引数:2,130
A
Aleksandra Gruslova
H 指数:12论文数:93被引数:556